Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
16
NMPA:16
Drug Approvals
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20254159
- Approval Date
- May 13, 2025
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20254158
- Approval Date
- May 13, 2025
NMPA
Carbazochrome Sodium Sulfonate Injection
- Product Name
- 卡络磺钠注射液
- Approval Number
- 国药准字H20253830
- Approval Date
- Apr 8, 2025
NMPA
Carbazochrome Sodium Sulfonate Injection
- Product Name
- 卡络磺钠注射液
- Approval Number
- 国药准字H20253819
- Approval Date
- Apr 8, 2025
NMPA
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution
- Product Name
- 硫酸镁钠钾口服用浓溶液
- Approval Number
- 国药准字H20253056
- Approval Date
- Jan 2, 2025
NMPA
Phloroglucinol Injection
- Product Name
- 间苯三酚注射液
- Approval Number
- 国药准字H20234415
- Approval Date
- Oct 27, 2023
NMPA
Oseltamivir Phosphate Granules
- Product Name
- 磷酸奥司他韦颗粒
- Approval Number
- 国药准字H20234026
- Approval Date
- Aug 8, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found